Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of These 10 Stocks Are Making Big Moves. Viking Therapeutics jumped by 9.74 ...

GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO, ...

BEACON and Open-Label Extension Study Design and Data Summary: ...

NMRA-861 has demonstrated a potentially best-in-class pharmacological profile and robust activity in preclinical efficacy models. NMRA-861 was safe and well-tolerated in pre-clinical toxicology ...

In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer ("mCRPC"),the six-month radiographic progres ...

The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases. This rise ...

Takeda is pleased to announce the publication of its 2025 Annual Integrated Report. The Report is available in both English ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...